MEDP Insider Transactions
| Transaction Date (SEC Report ) |
Reporting Name | Relationship | Shrs. Owned | Type | Acq./Disp. | Shrs. Transacted | Price() | Amount() |
|---|---|---|---|---|---|---|---|---|
| 2023-02-17 | EWALD STEPHEN P | officer: General Counsel & Corp. Secy. | 1,000 | A-Award | A | 1,000 | 0.00 | 0.00 |
| 2023-02-17 | Brady Kevin M. | officer: CFO & Treasurer | 1,000 | A-Award | A | 1,000 | 0.00 | 0.00 |
| 2023-02-17 | BURWIG SUSAN E | officer: Exec. VP, Operations | 1,000 | A-Award | A | 1,000 | 0.00 | 0.00 |
| 2023-02-17 | GEIGER JESSE J | officer: President | 1,000 | A-Award | A | 1,000 | 0.00 | 0.00 |
| 2023-02-17 | Troendle August J. | director, 10 percent owner, officer: CEO | 1,000 | A-Award | A | 1,000 | 0.00 | 0.00 |
| 2023-01-16 | Gwadry-Sridhar Femida H. | director | 573 | A-Award | A | 573 | 0.00 | 0.00 |
| 2023-01-16 | Gwadry-Sridhar Femida H. | None | 0 | None | None | 0.00 | ||
| 2023-01-16 | Gwadry-Sridhar Femida H. | director: | 0 | 0 | 0.00 | 0.00 | ||
| 2022-12-09 | Kraft Robert O. | director | 376 | A-Award | A | 376 | 205.77 | 77,369.52 |
| 2022-12-09 | McCarthy Cornelius P. III | director | 328 | A-Award | A | 328 | 205.77 | 67,492.56 |
| 2022-12-09 | Carley Brian T | director | 413 | A-Award | A | 413 | 205.77 | 84,983.01 |
| 2022-11-15 | Brady Kevin M. | officer: CFO & Treasurer | 3,344 | S-Sale | D | 1,656 | 229.30 | 379,720.80 |
| 2022-11-16 | Brady Kevin M. | officer: CFO & Treasurer | 3,000 | S-Sale | D | 344 | 227.09 | 78,118.96 |
| 2022-11-15 | GEIGER JESSE J | officer: President | 13,382 | M-Exempt | A | 7,000 | 28.32 | 198,240.00 |
| 2022-11-15 | GEIGER JESSE J | officer: President | 6,382 | S-Sale | D | 7,000 | 230.00 | 1,610,000.00 |
| 2022-11-15 | GEIGER JESSE J | officer: President | 0 | M-Exempt | D | 7,000 | 0.00 | 0.00 |
| 2022-11-01 | Kraft Robert O. | director | 9,630 | M-Exempt | A | 9,630 | 23.00 | 221,490.00 |
| 2022-11-01 | Kraft Robert O. | director | 0 | S-Sale | D | 9,630 | 221.42 | 2,132,274.60 |
| 2022-11-01 | Kraft Robert O. | director | 0 | M-Exempt | D | 9,630 | 0.00 | 0.00 |
| 2022-10-27 | EWALD STEPHEN P | officer: General Counsel & Corp. Secy. | 21,354 | M-Exempt | A | 6,500 | 32.05 | 208,325.00 |
| 2022-10-27 | EWALD STEPHEN P | officer: General Counsel & Corp. Secy. | 14,854 | S-Sale | D | 6,500 | 220.53 | 1,433,445.00 |
| 2022-10-27 | EWALD STEPHEN P | officer: General Counsel & Corp. Secy. | 0 | M-Exempt | D | 6,500 | 0.00 | 0.00 |
| 2022-09-22 | Medpace Investors, LLC | 10 percent owner | 6,483,019 | P-Purchase | A | 57,426 | 154.59 | 8,877,485.34 |
| 2022-09-22 | Troendle August J. | director, 10 percent owner, officer: CEO | 6,483,019 | P-Purchase | A | 57,426 | 154.59 | 8,877,485.34 |
| 2022-09-20 | Troendle August J. | director, 10 percent owner, officer: CEO | 6,331,474 | P-Purchase | A | 94,119 | 155.14 | 14,601,621.66 |
| 2022-09-21 | Troendle August J. | director, 10 percent owner, officer: CEO | 6,425,593 | P-Purchase | A | 94,119 | 161.63 | 15,212,453.97 |
| 2022-09-20 | Medpace Investors, LLC | 10 percent owner | 6,331,474 | P-Purchase | A | 94,119 | 155.14 | 14,601,621.66 |
| 2022-09-21 | Medpace Investors, LLC | 10 percent owner | 6,425,593 | P-Purchase | A | 94,119 | 161.63 | 15,212,453.97 |
| 2022-09-16 | Medpace Investors, LLC | 10 percent owner | 6,143,236 | P-Purchase | A | 62,516 | 149.58 | 9,351,143.28 |
| 2022-09-19 | Medpace Investors, LLC | 10 percent owner | 6,237,355 | P-Purchase | A | 94,119 | 153.48 | 14,445,384.12 |
| 2022-09-16 | Troendle August J. | director, 10 percent owner, officer: CEO | 6,143,236 | P-Purchase | A | 62,516 | 149.58 | 9,351,143.28 |
| 2022-09-19 | Troendle August J. | director, 10 percent owner, officer: CEO | 6,237,355 | P-Purchase | A | 94,119 | 153.48 | 14,445,384.12 |
| 2022-09-14 | Troendle August J. | director, 10 percent owner, officer: CEO | 6,018,204 | P-Purchase | A | 62,516 | 152.66 | 9,543,692.56 |
| 2022-09-15 | Troendle August J. | director, 10 percent owner, officer: CEO | 6,080,720 | P-Purchase | A | 62,516 | 153.11 | 9,571,824.76 |
| 2022-09-14 | Medpace Investors, LLC | 10 percent owner | 6,018,204 | P-Purchase | A | 62,516 | 152.66 | 9,543,692.56 |
| 2022-09-15 | Medpace Investors, LLC | 10 percent owner | 6,080,720 | P-Purchase | A | 62,516 | 153.11 | 9,571,824.76 |
| 2022-09-12 | Troendle August J. | director, 10 percent owner, officer: CEO | 5,893,172 | P-Purchase | A | 62,515 | 167.58 | 10,476,263.70 |
| 2022-09-13 | Troendle August J. | director, 10 percent owner, officer: CEO | 5,955,688 | P-Purchase | A | 62,516 | 157.12 | 9,822,513.92 |
| 2022-09-12 | Medpace Investors, LLC | 10 percent owner | 5,893,172 | P-Purchase | A | 62,515 | 167.58 | 10,476,263.70 |
| 2022-09-13 | Medpace Investors, LLC | 10 percent owner | 5,955,688 | P-Purchase | A | 62,516 | 157.12 | 9,822,513.92 |
| 2022-09-08 | Troendle August J. | officer: CEO | 5,830,657 | P-Purchase | A | 56,557 | 164.33 | 9,294,011.81 |
| 2022-09-08 | Medpace Investors, LLC | director: | 5,774,100 | P-Purchase | A | 56,557 | 157.65 | 8,916,211.05 |
| 2022-09-06 | Medpace Investors, LLC | director: | 5,717,543 | P-Purchase | A | 56,557 | 150.72 | 8,524,271.04 |
| 2022-09-06 | Troendle August J. | officer: CEO | 5,717,543 | P-Purchase | A | 56,557 | 150.72 | 8,524,271.04 |
| 2022-09-01 | Medpace Investors, LLC | director: | 5,555,715 | P-Purchase | A | 42,076 | 144.52 | 6,080,823.52 |
| 2022-09-01 | Troendle August J. | officer: CEO | 5,555,715 | P-Purchase | A | 42,076 | 144.52 | 6,080,823.52 |
| 2022-07-18 | Troendle August J. | officer: CEO | 5,513,639 | P-Purchase | A | 8,330 | 145.00 | 1,207,850.00 |
| 2022-07-18 | Medpace Investors, LLC | director: | 5,513,639 | P-Purchase | A | 8,330 | 145.00 | 1,207,850.00 |
| 2022-07-14 | Troendle August J. | officer: CEO | 5,505,309 | P-Purchase | A | 22,290 | 144.59 | 3,222,911.10 |
| 2022-07-14 | Medpace Investors, LLC | director: | 5,505,309 | P-Purchase | A | 22,290 | 144.59 | 3,222,911.10 |
| 2022-05-20 | Carley Brian T | director: | 1,903 | A-Award | A | 1,903 | 0.00 | 0.00 |
| 2022-05-20 | Kraft Robert O. | director: | 1,903 | A-Award | A | 1,903 | 0.00 | 0.00 |
| 2022-05-20 | McCarthy Cornelius P. III | director: | 1,903 | A-Award | A | 1,903 | 0.00 | 0.00 |
| 2022-05-20 | DAVENPORT FRED B JR | director: | 1,903 | A-Award | A | 1,903 | 0.00 | 0.00 |
| 2022-05-20 | Keating Ashley M. | director: | 1,903 | A-Award | A | 1,903 | 0.00 | 0.00 |
| 2022-05-20 | King Tom C | director: | 1,903 | A-Award | A | 1,903 | 0.00 | 0.00 |
| 2022-05-06 | EWALD STEPHEN P | officer: General Counsel & Corp. Secy. | 14,854 | M-Exempt | A | 1,000 | 32.05 | 32,050.00 |
| 2022-03-01 | Troendle August J. | officer: CEO | 0 | M-Exempt | D | 100,000 | 0.00 | 0.00 |
| 2022-02-23 | BURWIG SUSAN E | officer: Exec. VP, Operations | 20,183 | M-Exempt | A | 12,400 | 28.32 | 351,168.00 |
| 2022-02-23 | BURWIG SUSAN E | officer: Exec. VP, Operations | 0 | M-Exempt | D | 12,400 | 28.32 | 351,168.00 |
| 2022-02-17 | DAVENPORT FRED B JR | director | 2,000 | P-Purchase | A | 500 | 145.80 | 72,900.00 |
| 2022-02-15 | Brady Kevin M. | officer: CFO & Treasurer | 13,803 | A-Award | A | 13,803 | 138.87 | 1,916,822.61 |
| 2022-02-15 | EWALD STEPHEN P | officer: General Counsel & Corp. Secy. | 23,349 | A-Award | A | 23,349 | 138.87 | 3,242,475.63 |
| 2022-02-15 | GEIGER JESSE J | officer: President | 31,707 | A-Award | A | 31,707 | 138.87 | 4,403,151.09 |
| 2022-02-15 | BURWIG SUSAN E | officer: Exec. VP, Operations | 34,060 | A-Award | A | 34,060 | 138.87 | 4,729,912.20 |
| 2022-02-15 | Troendle August J. | director, 10 percent owner, officer: CEO | 93,174 | A-Award | A | 93,174 | 138.87 | 12,939,073.38 |
| 2022-01-04 | Troendle August J. | director, 10 percent owner, officer: CEO | 5,483,019 | S-Sale | D | 3,338 | 213.44 | 712,462.72 |
| 2022-01-04 | Medpace Investors, LLC | 10 percent owner | 5,483,019 | S-Sale | D | 3,338 | 213.44 | 712,462.72 |
| 2021-12-30 | Troendle August J. | director, 10 percent owner, officer: CEO | 5,519,170 | S-Sale | D | 17,376 | 220.34 | 3,828,627.84 |
| 2021-12-31 | Troendle August J. | director, 10 percent owner, officer: CEO | 5,506,101 | S-Sale | D | 13,069 | 219.14 | 2,863,940.66 |
| 2022-01-03 | Troendle August J. | director, 10 percent owner, officer: CEO | 5,486,357 | S-Sale | D | 19,744 | 212.70 | 4,199,548.80 |
| 2021-12-30 | Medpace Investors, LLC | 10 percent owner | 5,519,170 | S-Sale | D | 17,376 | 220.34 | 3,828,627.84 |
| 2021-12-31 | Medpace Investors, LLC | 10 percent owner | 5,506,101 | S-Sale | D | 13,069 | 219.14 | 2,863,940.66 |
| 2022-01-03 | Medpace Investors, LLC | 10 percent owner | 5,486,357 | S-Sale | D | 19,744 | 212.70 | 4,199,548.80 |
| 2021-12-28 | Troendle August J. | director, 10 percent owner, officer: CEO | 5,553,296 | S-Sale | D | 24,118 | 222.18 | 5,358,537.24 |
| 2021-12-29 | Troendle August J. | director, 10 percent owner, officer: CEO | 5,536,546 | S-Sale | D | 16,750 | 220.16 | 3,687,680.00 |
| 2021-12-28 | Medpace Investors, LLC | 10 percent owner | 5,553,296 | S-Sale | D | 24,118 | 222.18 | 5,358,537.24 |
| 2021-12-29 | Medpace Investors, LLC | 10 percent owner | 5,536,546 | S-Sale | D | 16,750 | 220.16 | 3,687,680.00 |
| 2021-12-23 | Troendle August J. | director, 10 percent owner, officer: CEO | 5,616,585 | S-Sale | D | 22,830 | 223.19 | 5,095,427.70 |
| 2021-12-27 | Troendle August J. | director, 10 percent owner, officer: CEO | 5,577,414 | S-Sale | D | 39,171 | 226.11 | 8,856,954.81 |
| 2021-12-23 | Medpace Investors, LLC | 10 percent owner | 5,616,585 | S-Sale | D | 22,830 | 223.19 | 5,095,427.70 |
| 2021-12-27 | Medpace Investors, LLC | 10 percent owner | 5,577,414 | S-Sale | D | 39,171 | 226.11 | 8,856,954.81 |
| 2021-12-21 | Troendle August J. | director, 10 percent owner, officer: CEO | 5,678,375 | S-Sale | D | 18,133 | 215.17 | 3,901,677.61 |
| 2021-12-22 | Troendle August J. | director, 10 percent owner, officer: CEO | 5,639,415 | S-Sale | D | 38,960 | 220.50 | 8,590,680.00 |
| 2021-12-21 | Medpace Investors, LLC | 10 percent owner | 5,678,375 | S-Sale | D | 18,133 | 215.17 | 3,901,677.61 |
| 2021-12-22 | Medpace Investors, LLC | 10 percent owner | 5,639,415 | S-Sale | D | 38,960 | 220.50 | 8,590,680.00 |
| 2021-12-17 | Troendle August J. | director, 10 percent owner, officer: CEO | 5,719,242 | S-Sale | D | 30,605 | 213.59 | 6,536,921.95 |
| 2021-12-20 | Troendle August J. | director, 10 percent owner, officer: CEO | 5,696,508 | S-Sale | D | 22,734 | 212.57 | 4,832,566.38 |
| 2021-12-17 | Medpace Investors, LLC | 10 percent owner | 5,719,242 | S-Sale | D | 30,605 | 213.59 | 6,536,921.95 |
| 2021-12-20 | Medpace Investors, LLC | 10 percent owner | 5,696,508 | S-Sale | D | 22,734 | 212.57 | 4,832,566.38 |
| 2021-12-15 | Troendle August J. | director, 10 percent owner, officer: CEO | 5,755,806 | S-Sale | D | 2,424 | 210.28 | 509,718.72 |
| 2021-12-16 | Troendle August J. | director, 10 percent owner, officer: CEO | 5,749,847 | S-Sale | D | 5,959 | 210.22 | 1,252,700.98 |
| 2021-12-15 | Medpace Investors, LLC | 10 percent owner | 5,755,806 | S-Sale | D | 2,424 | 210.28 | 509,718.72 |
| 2021-12-16 | Medpace Investors, LLC | 10 percent owner | 5,749,847 | S-Sale | D | 5,959 | 210.22 | 1,252,700.98 |
| 2021-12-09 | Troendle August J. | director, 10 percent owner, officer: CEO | 5,758,539 | S-Sale | D | 14,994 | 212.13 | 3,180,677.22 |
| 2021-12-10 | Troendle August J. | director, 10 percent owner, officer: CEO | 5,758,230 | S-Sale | D | 309 | 210.20 | 64,951.80 |
| 2021-12-09 | Medpace Investors, LLC | 10 percent owner | 5,758,539 | S-Sale | D | 14,994 | 212.13 | 3,180,677.22 |
| 2021-12-10 | Medpace Investors, LLC | 10 percent owner | 5,758,230 | S-Sale | D | 309 | 210.20 | 64,951.80 |
| 2021-12-07 | Troendle August J. | director, 10 percent owner, officer: CEO | 5,789,404 | S-Sale | D | 18,520 | 211.78 | 3,922,165.60 |
| 2021-12-08 | Troendle August J. | director, 10 percent owner, officer: CEO | 5,773,533 | S-Sale | D | 15,871 | 212.89 | 3,378,777.19 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Group doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Group or anyone involved with Discounting Cash Flows Group will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.